perfluoro tert-butylcyclohexane
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2009 (NCT00908063)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
FC(F)(F)C(C(F)(F)F)(C(F)(F)F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F- Mol. weight
- 500.07 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297413 ↗
Also known as
- oxycyte
- oxycyte
- oxycyte
- perfluoro tert-butylcyclohexane
- perfluoro tert-butylcyclohexane
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00908063 | Phase 2 | Oct 1, 2009 | Ospedale Regionale di Lugano, Tenax Therapeutics, Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ospedale Regionale di Lugano | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Tenax Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2009 |
2 organizations
Page 1 / 1